-
PharmeceuticalsKolon resumes Invossa phase 3 clinical trials in USKolon TissueGene Inc., the cell therapies unit of South Korean pharmaceutical company Kolon Life Science Inc., said on Dec. 28...
Dec 28, 2021 (Gmt+09:00)
-
Korean startupsGermany's ZF to invest in Korean self-driving startupGermany's car parts maker ZF Friedrichshafen is in the final stages of negotiations to invest around 20 billion won ($17 million...
Dec 28, 2021 (Gmt+09:00)
-
Venture CapitalMobile POS maker Payhere receives $84.2 mn in Series A fundingMobile point-of-sale (POS) system maker Payhere Inc. announced Tuesday it received 10 billion won ($8.4 million) in Series A fun...
Dec 28, 2021 (Gmt+09:00)
-
Mergers & AcquisitionsAffinity picks Goldman as adviser for Burger King Korea, Japan salesAffinity Equity Partners has chosen Goldman Sachs as its adviser for the planned sale of its entire stakes in Burger King’...
Dec 28, 2021 (Gmt+09:00)
-
Pension fundsKFCC to increase alternative assets to 40% in three yearsMG Korean Federation of Community Credit Cooperatives (KFCC) will gradually increase its alternative investment proportion from ...
Dec 28, 2021 (Gmt+09:00)
-
Executive reshufflesCJ Group promotes chairman’s son, signals 3rd-generation successionSouth Korea's CJ Group promoted the group chairman's son Lee Sun-ho to a new executive-level position Monday, paving the way f...
Dec 28, 2021 (Gmt+09:00)
-
Year-end reviewKosdaq: Perennial bush league as blue chips favor KospiSouth Korea’s tech-heavy Kosdaq market has been underperforming the main Kospi market for a couple of decades, raising con...
Dec 28, 2021 (Gmt+09:00)
-
Mergers & AcquisitionsE-Mart in exclusive talks to buy US food companySouth Korea's largest supermarket chain E-Mart Inc. has spent nearly $4 billion on acquisition deals so far this year, including...
Dec 28, 2021 (Gmt+09:00)